Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection

Biochemical and Biophysical Research Communications

Volumn 414, Issue 2, 2011, Pages 344-349

  Ma, Ning ^a   Thanan, Raynoo ^a,b   Kobayashi, Hatasu ^b   Hammam, Olfat ^c   Wishahi, Mohamed ^c   Leithy, Tarek El ^c   Hiraku, Yusuke ^b   Amro, EL Karef ^b,d   Oikawa, Shinji ^b   Ohnishi, Shiho ^a   Murata, Mariko ^b   Kawanishi, Shosuke ^a,b  

^a SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

Bladder cancer; Inflammation; INOS; Nitrative DNA damage; Oct3 4; Stem cells

Indexed keywords

8 NITROGUANINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; OCTAMER TRANSCRIPTION FACTOR 4;

ARTICLE; BLADDER CANCER; CANCER PATIENT; CONTROLLED STUDY; CYSTITIS; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NITRATIVE STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; TUMOR BIOPSY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYSTITIS; DEOXYGUANOSINE; DNA DAMAGE; GUANINE; HUMANS; NEOPLASTIC STEM CELLS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OCTAMER TRANSCRIPTION FACTOR-3; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; URINARY BLADDER NEOPLASMS;

SCHISTOSOMA HAEMATOBIUM;

EID: 80054837215     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.073     Document Type: Article

References (37)

1. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
2. IARC, Infection with Schistosomes, Liver Flukes and Helicobacter Pylori, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, IARC Monogr. Eval. Carcinog. Risks Hum. 61 (1994) 45-119.
3. Rollinson D. A wake up call for urinary schistosomiasis: reconciling research effort with public health importance. Parasitology 2009, 136:1593-1610.
4. Vennervald B.J., Polman K. Helminths and malignancy. Parasite Immunol. 2009, 31:686-696.
5. Federico A., Morgillo F., Tuccillo C., Ciardiello F., Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 2007, 121:2381-2386.
6. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem. J. 2007, 401:1-11.
7. Valavanidis A., Vlachogianni T., Fiotakis C. 8-Hydroxy-2'-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2009, 27:120-139.
8. Hiraku Y. Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance. Environ. Health Prev. Med. 2010, 15:63-72.
9. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
10. Shipitsin M., Polyak K. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab. Invest. 2008, 88:459-463.
11. Shin K., Lee J., Guo N., Kim J., Lim A., Qu L., Mysorekar I.U., Beachy P.A. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 2011, 472:110-114.
12. Bryan R.T. Bladder cancer and cancer stem cells: basic science and implications for therapy. Sci. World J. 2011, 11:1187-1194.
13. Tran M.N., Goodwin Jinesh G., McConkey D.J., Kamat A.M. Bladder cancer stem cells. Curr. Stem Cell Res. Ther. 2010, 5:387-395.
14. Looijenga L.H., Stoop H., de Leeuw H.P., de Gouveia Brazao C.A., Gillis A.J., van Roozendaal K.E., van Zoelen E.J., Weber R.F., Wolffenbuttel K.P., van Dekken H., Honecker F., Bokemeyer C., Perlman E.J., Schneider D.T., Kononen J., Sauter G., Oosterhuis J.W. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003, 63:2244-2250.
15. Atlasi Y., Mowla S.J., Ziaee S.A., Bahrami A.R. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int. J. Cancer 2007, 120:1598-1602.
16. Chang C.C., Shieh G.S., Wu P., Lin C.C., Shiau A.L., Wu C.L. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res. 2008, 68:6281-6291.
17. Ezeh U.I., Turek P.J., Reijo R.A., Clark A.T. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005, 104:2255-2265.
18. Bentivegna A., Conconi D., Panzeri E., Sala E., Bovo G., Vigano P., Brunelli S., Bossi M., Tredici G., Strada G., Dalpra L. Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples. Cancer Sci. 2010, 101:416-424.
19. J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn (Eds.), World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2004, pp. 124-127.
20. F.K. Mostofi, L.H. Sobin, H. Torloni, Histological Typing of Urinary Bladder Tumours: International Classification of Tumours, vol. 10, World Health Organization, Geneva, Switzerland, 1973, pp. 21-31.
21. Shaker Z.A., Kaddah M.A., Hanallah S.B., El-Khodary M.I. Production of monoclonal antibodies against target schistosomal antigen secreted in the urine of Schistosoma mansoni-infected patients. Int. J. Parasitol. 1998, 28:1893-1901.
22. Pinlaor S., Hiraku Y., Ma N., Yongvanit P., Semba R., Oikawa S., Murata M., Sripa B., Sithithaworn P., Kawanishi S. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide 2004, 11:175-183.
23. Salim E.I., Morimura K., Menesi A., El-Lity M., Fukushima S., Wanibuchi H. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int. J. Cancer 2008, 123:601-608.
24. Bruner S.D., Norman D.P., Verdine G.L. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 2000, 403:859-866.
25. Yermilov V., Rubio J., Ohshima H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 1995, 376:207-210.
26. Wu X., Takenaka K., Sonoda E., Hochegger H., Kawanishi S., Kawamoto T., Takeda S., Yamazoe M. Critical roles for polymerase ζ in cellular tolerance to nitric oxide-induced DNA damage. Cancer Res. 2006, 66:748-754.
27. Loeb L.A., Preston B.D. Mutagenesis by apurinic/apyrimidinic sites. Annu. Rev. Genet. 1986, 20:201-230.
28. Kawanishi S., Hiraku Y., Pinlaor S., Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 2006, 387:365-372.
29. Yermilov V., Rubio J., Becchi M., Friesen M.D., Pignatelli B., Ohshima H. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 1995, 16:2045-2050.
30. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 2001, 480-481:243-268.
31. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
32. Wamachi A.N., Mayadev J.S., Mungai P.L., Magak P.L., Ouma J.H., Magambo J.K., Muchiri E.M., Koech D.K., King C.H., King C.L. Increased ratio of tumor necrosis factor-α to interleukin-10 production is associated with Schistosoma haematobium-induced urinary-tract morbidity. J. Infect. Dis. 2004, 190:2020-2030.
33. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
34. Maitland N.J., Collins A.T. Inflammation as the primary aetiological agent of human prostate cancer: a stem cell connection?. J. Cell. Biochem. 2008, 105:931-939.
35. Tanno T., Matsui W. Development and maintenance of cancer stem cells under chronic inflammation. J. Nihon Med. Sch. 2011, 78:138-145.
36. North T.E., Goessling W., Walkley C.R., Lengerke C., Kopani K.R., Lord A.M., Weber G.J., Bowman T.V., Jang I.H., Grosser T., Fitzgerald G.A., Daley G.Q., Orkin S.H., Zon L.I. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007, 447:1007-1011.
37. Logan C.M., Giordano A., Puca A., Cassone M. Prostaglandin E2: at the crossroads between stem cell development, inflammation and cancer. Cancer Biol. Ther. 2007, 6:1517-1520.